Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome (Q61241): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A síndrome de Kearns-Sayre é uma doença neuromuscular mitocondrial rara, geralmente esporádica, caracterizada por perda auditiva neurossensorial progressiva, oftalmoplegia, ptose, retinite pigmentar e envolvimento do sistema nervoso central (ataxia cerebelar, disartria, fraqueza facial bilateral, déficit intelectual), bem como cardiomiopatia hipertrófica e defeitos de condução cardíaca. | |||
| description / en | description / en | ||
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects. | |||
Revision as of 08:43, 14 August 2026
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_605176031 |
||
| English | Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome |
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects. |
